Cumin and Rivaroxaban Safety

Evidence Review

The American College of Chest Physicians suggests that cumin can be safely consumed while taking rivaroxaban, as there is no documented interaction between this common culinary spice and the anticoagulant, with rivaroxaban being metabolized primarily through the CYP3A4 enzyme and P-glycoprotein transporter 1, 2
The American Heart Association indicates that strong dual inhibitors of CYP3A4 and P-glycoprotein, such as azole antifungals and HIV protease inhibitors, should be avoided as they can increase rivaroxaban plasma concentrations by approximately 2.5-fold, significantly elevating bleeding risk 1, 2

The European Society of Cardiology recommends avoiding strong CYP3A4 inducers, such as rifampicin, phenytoin, carbamazepine, and phenobarbital, as they decrease rivaroxaban effectiveness by reducing plasma concentrations by approximately 50% 1, 2
The American College of Clinical Pharmacology states that cumin is not listed among substances that inhibit or induce CYP3A4, CYP2J2, or P-glycoprotein transporters in any of the comprehensive drug interaction guidelines for rivaroxaban, and as a common culinary spice used in typical food preparation amounts, cumin does not affect rivaroxaban pharmacokinetics or pharmacodynamics 1, 2

The International Society on Thrombosis and Haemostasis advises that higher doses of rivaroxaban (15 mg and 20 mg) must be taken with food to ensure adequate absorption and bioavailability ≥80%, preferably with the evening meal, while lower doses (2.5 mg and 10 mg) can be taken with or without food 3
The American Heart Association recommends monitoring for signs of bleeding, such as unusual bruising, prolonged bleeding, black stools, and blood in urine, regardless of diet, and being cautious with NSAIDs, which increase bleeding risk when combined with rivaroxaban through additive antiplatelet effects 4